PRP vs. Microneedling vs. Plasma vs. Meds for Hair: Ranked, Bluntly

Too Many Settings, and a Moment That Matters

Alexander E. Bonato, MD — Board-Certified in Internal Medicine (American Board of Internal Medicine) · Medically reviewed November 2026.

The short answer: Hair-loss treatment isn't a pick-one contest. Minoxidil and finasteride have the deepest evidence, so I treat them as the foundation and the procedures as add-ons.^1,2 Microneedling has several trials, mostly as an add-on to minoxidil; PRP has a growing pile of small studies; both are promising rather than proven. Plasma is still experimental. The plan that usually makes sense is a combination built around your goals — medications when they're a fit, with procedures layered on — not a single gadget and not PRP alone.

At Bonato MD Aesthetics in Medford, hair care is a full physician-led program: diagnosis and scalp analysis first, then a plan that can combine medications and procedures. For how that program is built, see our physician-led hair restoration in Medford page.

---

I'm terrible at photos. My camera roll is decapitated landmarks, my own thumb, and portraits shot at an angle that suggests I was mid-fall.

Hand me a camera with too many settings and a moment that matters, and I'll find a way to point it at the ground.

Anyway. Hair loss has the same problem: too many settings, a moment that matters, and a pull toward whichever option has the flashiest marketing. I'm a physician board-certified in Internal Medicine (American Board of Internal Medicine) who practices aesthetic medicine at Bonato MD Aesthetics in Medford. I prescribe hair medications here, and I do PRP, microneedling and scalp plasma, so I have a stake in every option on this list. Here's how I'd line them up, and where the evidence runs out.

Start With the Diagnosis, Not the Treatment

Pattern hair loss is progressive. Follicles gradually shrink, and thick hairs get replaced by finer, shorter ones.^3,4 Shedding, patchy loss and scalp conditions are different problems with a different first step. The over-the-counter minoxidil labels say not to use it if your hair loss is sudden or patchy or you don't know the cause,^5,6 and a 2026 review advises a specialist referral when the diagnosis is unclear, scarring is possible, or there's itching, burning or pain.³

Here's how the first visit goes. I put a magnified camera on your scalp to measure hair density and shaft width, and we repeat it at every visit, so your response is tracked against your own baseline. Then we talk about stress, nutrition and sleep, and only then about options.

It's the only camera anyone trusts me with.

Foundation First, Add-Ons Second

Stop asking which one treatment to get and start thinking in layers. The foundation is the treatment with the deepest evidence, and for hair loss that's medication.^1,2,4,7,8 In one 2023 network meta-analysis, an indirect comparison across 27 trials, procedures on their own ranked below minoxidil alone, and microneedling added to minoxidil ranked highest.² The add-ons are procedures that may boost the foundation. That framing is mine, not a trial result.

If you want the photography version: meds are the tripod, and the procedures are the lenses and filters. Fun to play with. It helps to know which one is holding the camera up.

The Foundation: Medications

Medication isn't photogenic. Nobody posts their bathroom shelf. It's still where I start.

Topical minoxidil is sold over the counter. The labels say you may need at least 4 months of twice-daily use before you see results (up to 8 months on the women's 2% label), and that you'll probably lose the newly regrown hair in 3 to 4 months if you stop.^5,6 Low-dose oral minoxidil is an off-label use of a tablet approved only for severe high blood pressure.⁹ In small randomized trials it did about as well as the topical, not clearly better, and it caused more unwanted facial and body hair.^10,11 I prescribe both forms of minoxidil, but never the pill and the topical together. That's my own practice, not a label rule.

Finasteride is a daily pill that lowers DHT, a hormone found at higher levels in balding scalp.¹² In two one-year placebo-controlled trials in men, finasteride 1 mg grew more hair than placebo,⁷ and a systematic review of 12 randomized trials rated that evidence moderate quality.⁸ In women it's off-label, and a one-year trial of 1 mg in postmenopausal women found no benefit.^12,13 I can prescribe it as a pill or in a compounded topical when it's a good fit. Compounded drugs aren't FDA-approved, so the FDA doesn't verify their safety, effectiveness or quality before they're sold.¹⁴ Going topical doesn't mean skipping the fine print: the FDA has flagged reports of side effects with compounded topical finasteride that are consistent with those reported for the pill.¹⁵

The catch with both drugs is the schedule. The minoxidil labels say continued use is needed to keep the regrowth,^5,6 and finasteride's effect fades after stopping, over about 12 months.¹² That's what sends a lot of people looking at procedures.

Microneedling: Mostly Studied as an Add-On to Minoxidil

In a 2013 pilot, 100 men were randomized to weekly microneedling plus 5% minoxidil or to minoxidil alone, and 94 were analyzed (50 and 44). At 12 weeks, the average hair count in a tattoo-marked 1 cm² patch had risen by 91.4 in the microneedling group and 22.2 in the minoxidil-only group.¹⁶ A 2025 meta-analysis of 12 randomized trials found more hair with microneedling plus minoxidil than with minoxidil alone, but the trials varied widely, and every one raised concerns about randomization.¹⁷

So has microneedling been studied without minoxidil? Yes, but the results are thin and mixed. In one 2024 study of 92 men (described under PRP below), hair number and density rose in the microneedling-only group.¹⁸ A 2023 randomized study of 30 men using microneedling alone (roller or tattoo cartridge, four monthly sessions) found no benefit in hair density.¹⁹ None of this tells us you can swap microneedling in for minoxidil and keep your hair.

In women the picture is mixed. A 2022 trial of 40 women found that weekly microneedling added benefit to 2% minoxidil.²⁰ A 2026 open-label trial of 245 women, the larger of the two, found no added benefit after 24 weeks, using a 500 to 550 µm needle depth every 2 or 4 weeks.²¹ Needle depth (0.5 to 1.5 mm where reported), interval and device differ from study to study, and the authors of several say there's no standard protocol.^16,17,18,21 I'd say I sympathize, but you've seen my camera roll.

Scalp microneedling for hair is also off-label. The FDA has cleared some microneedling devices for facial acne scars, facial wrinkles and abdominal scars in adults 22 and older, but says it hasn't cleared any for hair loss, even as studies continue.²² More in microneedling for hair loss.

PRP: Promising, With a Pile of Small Studies

PRP sounds like a medical-drama plot twist. It's a blood draw and a centrifuge.

PRP uses platelets concentrated from your own blood, injected into the scalp. A 2024 meta-analysis limited to randomized trials (14 trials, 431 people) found PRP added about 28 hairs per cm² more than placebo on average, but rated the evidence low certainty, because the studies varied widely and showed signs of publication bias.²³ More numbers in PRP for hair loss.

Against minoxidil, PRP has no clear winner. A 2026 review of nine randomized trials (451 people) found no clear advantage for PRP over topical minoxidil on hair density, though satisfaction and the hair-pull test favored PRP.²⁴

The only microneedling-versus-PRP head-to-head I can point to is small. In a 2024 study of 92 men randomly assigned to microneedling alone, microneedling plus minoxidil, or PRP, hair number and density rose in all three groups over five months with no clear difference between them, and only the PRP group's hair shaft thickness rose significantly. The PRP group was younger and had started losing hair earlier, and there was no sham or minoxidil-only group.¹⁸ That's why I call the order of microneedling and PRP a close call.

PRP is thought to work on follicles that are still alive, so an area that's been smooth and shiny for years is less likely to respond.¹ That's the reviewers' reasoning, not a trial result.

Plasma: The Experimental One

Plasma has the coolest name on this list, which is not a study design. For hair, it's the newest and least proven option here. The theory is that a controlled micro-injury to the scalp might trigger healing signals. I'm not aware of that being shown in people. The research is mostly lab work and small studies of a different technology, cold atmospheric plasma. On the human side I found two small reports, both uncontrolled: one of that other kind of plasma, and one that used a plasma device that wasn't named together with an exosome product, so the plasma's effect can't be separated.^25,26 Neither tested the plasma-arc device we use on the scalp.

I'm not aware of a published study of that device on the scalp, so I can't tell you it works for hair. It's part of one of our programs, so I'll tell you where I land: experimental, a possible adjunct, never a headline, and never a plan built on plasma alone. More in plasma for hair restoration and PLEXR Plus plasma.

Where the Thulium Laser and Topical Exosomes Fit

The 1927 nm thulium laser has small hair studies, mostly 9 to 16 people, plus a 2026 randomized pilot of 30.^{27,28,29,30,31} A 2026 review of fractional lasers found only one 1927 nm study, and its result wasn't statistically significant. The authors said the data on that wavelength were too limited for definitive conclusions.³² I'm not aware of a study that compares the laser with no laser, so I use it as an adjunct, never on its own. See the 1927 nm thulium laser.

Exosome products are applied topically to the scalp, never injected. The hair evidence is mostly from animals,³³ and the FDA says there are currently no FDA-approved exosome products.^34,35 I treat them as an add-on inside a plan, not as proven for hair. More in exosomes for skin.

The Ranking, by Evidence

1. Medications (minoxidil, finasteride). The deepest evidence.^1,2 The tradeoff is the schedule and the side effects.
2. Microneedling (tied with PRP). Several randomized trials, mostly as an add-on, with mixed results in women.^17,21
3. PRP (tied with microneedling). Growing but small studies, low certainty overall.²³
4. Plasma. Experimental for hair. At most an adjunct.

Microneedling and PRP trade places depending on the study, so treat them as tied. The order of 2 and 3 is only how I listed them. I haven't ranked the thulium laser or topical exosomes, since they're add-ons.

The Downsides, Plainly

Hair loss is personal, so here are the uncomfortable facts too.

• Topical minoxidil. The label says to stop and ask a doctor if you get scalp irritation or redness, unwanted facial hair, chest pain, a rapid heartbeat, faintness or dizziness, swollen hands or feet, or sudden, unexplained weight gain.^5,6
• Oral minoxidil. The tablet's label carries a boxed warning: minoxidil can cause fluid to build up around the heart (pericardial effusion) and can make angina worse.⁹ At the low doses used for hair loss, oral minoxidil can still cause fluid retention, usually mild ankle or leg swelling in the first few months, reported in roughly 1% to 9% of people depending on the study and tending to rise with dose, and rarely fluid around the heart.^{9,36,37,38,39} In a retrospective study of 1,404 people on low-dose oral minoxidil, unwanted hair growth was the most common side effect (about 15%), and lightheadedness and a fast heartbeat were each reported in fewer than 2%.³⁶ A 2025 review calls severe events such as pericardial effusion extremely rare.³⁹ It isn't for everyone, which is why it starts with your medical history.
• Finasteride. It must not be used by anyone who is or may become pregnant. The label lists side effects that can include sexual and mood changes, so tell me right away if you notice either.¹²
• Microneedling. Microneedling devices in general can cause bleeding, bruising, redness, itching and peeling, and less commonly infection or changes in skin color.²² In the scalp trials, effects were mostly mild, and small studies can miss rarer problems.^17,21
• PRP. Reviews of PRP for hair describe mostly short-lived local effects, such as pain, pinpoint bleeding, headache and burning at the injection site, and no intolerable or high-risk effects reported in the trials reviewed. I couldn't find a rate for any of them.^1,23

None of that is meant to scare you off. It's the reason I want your history before I write a prescription or start a series.

How I Build a Plan

It comes down to how fast your hair loss is moving and how you feel about ongoing medication. If you're comfortable with daily minoxidil, and finasteride where it's appropriate, that foundation plus microneedling is the combination with the most trials behind it, though those trials were mostly in men and results in women conflict.^17,21,40 If lifelong medication is a hard no for you, we lean more on procedures, with the understanding that the medication-free path is less well established. Either way, the through-line is realistic expectations, consistency over months, and a plan built around your priorities rather than the treatment with the best advertising.

At our clinic, hair programs run three visits spaced eight weeks apart, with a digital scalp analysis at every visit. Prescription management is included when it's appropriate, and the optional Sustain Membership covers ongoing care after the program. I do stack treatments when a plan calls for it, for example laser with microneedling and PRP in the same session. I keep about two months between sessions, and the first session is deliberately not aggressive: I don't stack too many things at once, so I don't shock your scalp. That's how I practice, not a trial result.

Give it months, not weeks. The trials here ran about 12 to 24 weeks, the minoxidil labels say at least 4 months, and the finasteride label says 3 months or more.^5,6,12,16,21 The minoxidil labels also say hair loss may increase temporarily for up to 2 weeks after you start.^5,6 After a procedure, I tell patients that a temporary shed in the first weeks can happen. That's my experience; I couldn't find controlled studies of shedding after PRP, microneedling or laser.

Frequently Asked Questions

What's the single most effective hair loss treatment?

By the evidence, the medications: minoxidil and finasteride.^1,2 But "most effective on paper" and "best for you" aren't always the same thing, because the schedule and the side effects are real. That's why a plan beats a single pick. I say that as someone who has never chosen the right camera mode on the first try.

Can I avoid minoxidil entirely?

You can try. Procedures like microneedling and PRP have been studied, but the medication-free route is less well established, for the reasons above.^18,19,24 It's a legitimate choice that needs realistic expectations, not a promise. Nobody's required to be in a committed relationship with a dropper bottle.

Are the medications, microneedling and PRP FDA-approved or cleared for hair loss?

Topical minoxidil is sold over the counter for hair loss, and finasteride 1 mg is approved for male pattern hair loss in men.^5,12 Oral minoxidil and finasteride in women are off-label, and compounded products aren't FDA-approved.^9,12,13,14 The FDA says it hasn't cleared any microneedling device for hair loss,²² and PRP for hair is also off-label.⁴¹

How long until I know if it's working?

Months, not weeks, which is the least fun answer in hair loss. It's slow, slow, slow. That's what the scalp camera is for: we compare your hair against your own baseline instead of squinting at a part line and hoping.

Let's Build Your Plan, Right Here in Southern Oregon

Hair loss needs a plan, not another flashy gadget — and not a PRP-only menu. I see patients from Medford, Ashland and Grants Pass, and we'll go through the evidence for each option. Start with the deep dives on microneedling and PRP, then see how the pieces fit into a full program on our physician-led hair restoration in Medford page.

Come in, bring your questions and your history, and I'll bring the tripod.

Book a free consultation, no card required, at bonatomd.com/book, or call or text 541-243-7546. Your consultation includes a scalp analysis.

Your treatment plan is determined at your consultation with Dr. Bonato.

References

1. Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83(8):701-15. https://doi.org/10.1007/s40265-023-01880-x (Narrative review. Full text read by Lit Reviewer 2026-10-29. The "intact follicles" reasoning is the reviewers' statement, not a trial result.)
2. Gupta AK, Wang T, Bamimore MA, Polla Ravi S, Talukder M. Relative effects of minoxidil 5%, platelet-rich plasma, and microneedling in pattern hair loss: a systematic review and network meta-analysis. Skin Appendage Disord. 2023;9(6):397-406. https://doi.org/10.1159/000534196 (Network meta-analysis, 27 trials, 1,110 patients; indirect comparisons only. Abstract only.)
3. McMullen E, Aldien AS, Sibbald C, Donovan J. Female pattern hair loss. CMAJ. 2026;198(8):E295. https://doi.org/10.1503/cmaj.251058 (Clinical review. Full text read by Lit Reviewer 2026-10-29. Written about female pattern hair loss.)
4. van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;(5):CD007628. https://doi.org/10.1002/14651858.CD007628.pub4 (Cochrane systematic review, 47 trials, 5,290 women. Abstract read.)
5. Minoxidil topical solution 5% (for men): Drug Facts. DailyMed (label effective 2024-05-13). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a05bc954-d369-4eb6-8a7d-d68955af874f (Over-the-counter label; read 2026-10-29.)
6. L. Perrigo Company. Hair regrowth treatment, minoxidil topical solution 2% (for women): Drug Facts. DailyMed (label effective 2026-08-06). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1bf381e-8f13-4a7e-a2f6-ba750d4d67e7 (Over-the-counter label; read 2026-10-29.)
7. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-89. https://doi.org/10.1016/s0190-9622(98)70007-6 (Two 1-year placebo-controlled randomized trials, n=1,553 men; manufacturer study group. Abstract only.)
8. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-50. https://doi.org/10.1001/archdermatol.2010.256 (Systematic review of 12 randomized trials, 3,927 men; moderate-quality evidence. Abstract only.)
9. Par Health USA. Minoxidil tablets: prescribing information. DailyMed (posted 2026-06-11). https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f3800f0-b6da-4dfe-8c32-39bb5eb0262a (Prescription label; approved for hypertension only; boxed warning on pericardial effusion and angina.)
10. Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024;160(6):600-5. https://doi.org/10.1001/jamadermatol.2024.0284 (Double-blind randomized trial, n=90 men, 24 weeks; 24% dropped out; single center.)
11. Sobral MVS, Moreira JLML, Rodrigues LK, Rocha P, Pirolla RDC, Soares VG, et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol. 2025;64(3):479-84. https://doi.org/10.1111/ijd.17524 (Meta-analysis of 4 trials, n=279, 24 to 39 weeks. Abstract only.)
12. Organon LLC. Finasteride 1 mg tablets: prescribing information (revised 11/2023). DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f904709-65aa-44ce-b144-b4c8a0416e36 (Prescription label; approved for male pattern hair loss only; not indicated in women; postmarketing reports in section 6.2.)
13. Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5 Pt 1):768-76. https://doi.org/10.1067/mjd.2000.107953 (Double-blind placebo-controlled randomized trial, n=137 postmenopausal women, 1 year, 1 mg. Abstract only.)
14. US Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers (Regulatory guidance; read 2026-10-29.)
15. US Food and Drug Administration. FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products (2025). https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-consumers-potential-risks-associated-compounded (Regulatory alert; reports of adverse events consistent with those of the approved oral products; reports, not established causation; read 2026-10-30.)
16. Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013;5(1):6-11. https://doi.org/10.4103/0974-7753.114700 (Randomized evaluator-blinded pilot, 100 men randomized, 94 analyzed (50 vs 44), 12 weeks; both groups used 5% minoxidil; 1.5 mm roller weekly; coin-toss randomization, no sham. Full text read by Lit Reviewer.)
17. Ahmed KMA, Kozaa YA, Abuawwad MT, Al-Najdawi AI, Mahmoud YW, Ahmed AM, et al. Evaluating the efficacy and safety of combined microneedling therapy versus topical minoxidil in androgenetic alopecia: a systematic review and meta-analysis. Arch Dermatol Res. 2025;317(1):528. https://doi.org/10.1007/s00403-025-04032-1 (Meta-analysis, 12 randomized trials, 631 patients; hair count SMD 1.32, I-squared 88%; randomization concerns in all studies. Full text read by Lit Reviewer.)
18. Leonik S, Smoczok M, Bergler-Czop B. Evaluation of the efficacy of microneedling without and with minoxidil 5% and autologous platelet-rich plasma for androgenetic alopecia in men. Postepy Dermatol Alergol. 2024;41(5):505-14. https://doi.org/10.5114/ada.2024.143496 (92 men in three groups of about 30, three monthly sessions, 5-month follow-up; the PRP group was younger with earlier onset and lower baseline hair numbers; no sham or minoxidil-only arm. Full text read by Lit Reviewer.)
19. Kakizaki P, Contin LA, Barletta M, Machado CJ, Michalany NS, Valente NYS, et al. Efficacy and safety of scalp microneedling in male pattern hair loss. Skin Appendage Disord. 2023;9(1):18-26. https://doi.org/10.1159/000526215 (Randomized single-blinded study, 30 men, microneedling alone, no minoxidil; no benefit in hair density. Abstract only.)
20. Zhang Y, Sheng Y, Zeng Y, Hu R, Zhao J, Wang W, et al. Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population. J Cosmet Dermatol. 2022;21(12):6985-91. https://doi.org/10.1111/jocd.15424 (Randomized trial, 40 women, 24 weeks. Abstract only.)
21. Liu Y, Luo H, Yang S, Wang Z, Chen Y, Wu F, et al. Microneedle frequency adjunct to 2% minoxidil in female androgenetic alopecia: a randomized controlled trial. J Am Acad Dermatol. 2026 May 25 [online ahead of print]. https://doi.org/10.1016/j.jaad.2026.03.123 (Open-label single-center trial, 245 women randomized, 234 analyzed, 24 weeks; no between-group difference; funding partly from a biopharma company with no role in the study. Full text read by Lit Reviewer.)
22. US Food and Drug Administration. Microneedling devices: getting to the point on benefits, risks and safety. Consumer update. https://www.fda.gov/consumers/consumer-updates/microneedling-devices-getting-point-benefits-risks-and-safety (General microneedling, not scalp-specific; read 2026-10-29.)
23. Kieling L, Konzen AT, Zanella RK, Valente DS. Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized controlled trials. An Bras Dermatol. 2024;99(6):847-62. https://doi.org/10.1016/j.abd.2024.01.002 (Meta-analysis of randomized trials, 14 trials and 431 patients; density MD 27.55 hairs/cm², I-squared 96%; GRADE low for density; publication bias. Full text read by Lit Reviewer.)
24. Umar M, Anwar A, Shamim L, Ahmad O, Laique F, Mohiuddin M, et al. Comparative efficacy and safety of platelet rich plasma (PRP) versus topical minoxidil for androgenetic alopecia: a systematic review and meta-analysis. Aesthetic Plast Surg. 2026;50(3):1340-53. https://doi.org/10.1007/s00266-025-05394-7 (Meta-analysis, 9 randomized trials, 451 participants; high heterogeneity. Abstract only.)
25. Khan A, Malik S, Walia J, Fridman G, Fridman A, Friedman PC. Tolerability of six months indirect cold (physical) plasma treatment of the scalp for hair loss. J Drugs Dermatol. 2020;19(12):1177-80. https://doi.org/10.36849/JDD.2020.5186 (Uncontrolled pilot, 14 people; cold atmospheric plasma, not a plasma-arc device. Abstract only.)
26. Sydorchuk O, Pamela R, Vitale M, Pupo D, Seok N, Lee S, et al. Plasma and sonophoresis-assisted topical delivery of an exosome for androgenic alopecia. J Craniofac Surg. 2026. https://doi.org/10.1097/SCS.0000000000012762 (Single-arm pilot, 25 adults; plasma device not named; the plasma effect can't be separated from the exosome product. Abstract only.)
27. Cho SB, Zheng Z, Kang JS, Kim H. Therapeutic efficacy of 1,927-nm fractionated thulium laser energy and polydeoxyribonucleotide on pattern hair loss. Med Lasers. 2016;5(1):22-8. https://doi.org/10.25289/ml.2016.5.1.22 (Two-arm study, n=16; laser combined with other treatments; no no-laser arm.)
28. Cho SB, Goo BL, Zheng Z, Yoo KH, Kang JS, Kim H. Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study. Lasers Med Sci. 2018;33(4):851-9. https://doi.org/10.1007/s10103-018-2437-5 (Split-scalp study, n=10. Abstract only.)
29. Brownell N, et al. Combination of a non-ablative 1,927 nm thulium fiber fractional laser and autologous platelet-rich plasma in treatment of male androgenetic alopecia: a pilot study. Chula Med J. 2019;63(1):13-21. https://doi.org/10.58837/chula.cmj.63.1.3 (Uncontrolled pilot, n=9 men. Abstract only.)
30. Wardhani PH, Rahmatika A, Thendria T, Kinasih NCP, Sarkowi WK. Application of thulium 1927-nm laser for androgenic alopecia treatment in Indonesian patients. J Lasers Med Sci. 2025;16:e42. https://doi.org/10.34172/jlms.2025.42 (Uncontrolled study, n=10; photo scores only.)
31. Nguyen L, Schneider SW, Herberger K. Thulium laser-assisted delivery of growth factors for treating androgenetic alopecia: a randomized, controlled, clinical study. Lasers Med Sci. 2026;41(1). https://doi.org/10.1007/s10103-026-05066-1 (Randomized evaluator-blinded pilot, 30 patients in three groups of 10, published 2026-10-22; devices and serum supplied by the companies; no no-laser arm. Full text read by Lit Reviewer.)
32. Chen C, Wang S, Bi D, Wei AC, Guo S. Efficacy and safety of fractional laser therapy for androgenetic alopecia: a systematic review and meta-analysis. J Cosmet Dermatol. 2026;25(5):e70909. https://doi.org/10.1111/jocd.70909 (Systematic review and meta-analysis, 15 studies; only one 1927 nm dataset (MD 6.75, 95% CI -9.02 to 22.52); authors say the data were insufficient for definitive conclusions.)
33. Schaffer S, Tehrani L, Koechle B, Chandramohan P, Hilburn B, Aoki KC, Jacobs RJ. A scoping review of exosome delivery applications in hair loss. Cureus. 2025;17(3):e81152. https://doi.org/10.7759/cureus.81152 (Scoping review; 14 of 16 included articles were animal studies.)
34. US Food and Drug Administration. Public safety notification on exosome products (2019 Dec 6). https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products (Regulatory notice; read 2026-10-29.)
35. US Food and Drug Administration. Consumer alert on regenerative medicine products including stem cells and exosomes. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes (Regulatory consumer alert; says there are currently no FDA-approved exosome products. Read 2026-10-30.)
36. Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-51. https://pubmed.ncbi.nlm.nih.gov/33639244/ (Retrospective multicenter study, no control group; fluid retention 1.3%. Abstract only.)
37. Salas J, Esse I, Kincaid CM, Birda A, Choe S, Mesinkovska NA. Characterizing low-dose oral minoxidil-induced peripheral edema in alopecia patients. J Am Acad Dermatol. 2025;92(3):632-4. https://pubmed.ncbi.nlm.nih.gov/39557081/ (Retrospective research letter, 250 patients, 0.625 to 5 mg; peripheral edema in 22 (8.8%); no control group. No abstract on PubMed; full text read by Lit Reviewer 2026-10-30.)
38. Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Moreno-Arrones OM, Ortega-Quijano D, Fernandez-Nieto D, et al. Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data. Dermatol Ther. 2020;33(6):e14106. https://pubmed.ncbi.nlm.nih.gov/32757405/ (Pooled analysis, 14 studies, 442 patients, 0.25 to 5 mg; pedal edema 2%, associated with higher doses. Abstract only.)
39. Jimenez-Cauhe J, Lo Sicco KI, Shapiro J, Hermosa-Gelbard A, Burgos-Blasco P, Melian-Olivera A, et al. Characterization and management of adverse events of low-dose oral minoxidil treatment for alopecia: a narrative review. J Clin Med. 2025;14(6):1805. https://doi.org/10.3390/jcm14061805 (Narrative review. Full text read.)
40. Abdi P, Awad C, Anthony MR, Farkouh C, Kenny B, Maibach HI, et al. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis. Arch Dermatol Res. 2023;315(10):2775-85. https://doi.org/10.1007/s00403-023-02688-1 (Systematic review of 10 randomized trials, 466 patients; 8 pooled, hair count SMD 1.76. Abstract only.)
41. International Society of Hair Restoration Surgery. Platelet-rich plasma (patient information). https://ishrs.org/patients/treatments-for-hair-loss/medications/platelet-rich-plasma/ (Professional society patient page; says PRP systems are FDA-cleared for orthopedic indications and hair use is off-label. Read 2026-10-29.)